Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells
- 1 August 2016
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 82, 256-268
Abstract
No abstract availableKeywords
Funding Information
- National University of Singapore
This publication has 41 references indexed in Scilit:
- Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent mannerMolecular Biology Reports, 2013
- Telomerase as a useful target in cancer fighting—the breast cancer caseTumor Biology, 2013
- Heterogeneity in breast cancerJournal of Clinical Investigation, 2011
- Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4Molecular Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Mutant p53 mediates survival of breast cancer cellsBritish Journal of Cancer, 2009
- Triple negative tumours: a critical reviewHistopathology, 2007
- The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance–linked ATP binding cassette drug transporter ABCG2Molecular Cancer Therapeutics, 2007
- Facile Synthesis of Naphthoquinone Spiroketals by Diastereoselective Oxidative [3 + 2] CycloadditionOrganic Letters, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006